BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells

Author(s):
Campbell, A.E.; Oliva, J.; Yates, M.P.; Zhong, J.W.; Shadle, S.C.; Snider, L.; Singh, N.; Tai, S.; Hiramuki, Y.; Tawil, R.; Maarel, S.M. van der (0000-0001-8103-711X); Tapscott, S.J.; Sverdrup, F.M.
Published
2017
Publication type
Article / Letter to editor
Facioscapulohumeral muscular dystrophyFSHDDUX4BromodomainAdrenergicHigh-throughput screening
Date issued
2017-09-04
Language
English
Is part of
Skeletal Muscle
hdl
1887/94921
doi
10.1186/s13395-017-0134-x